Dao Hong Nhung, MSc
Research Insitute of Stem Cell and Gene Therapy
Quality Control Officer
Biography
MSc. Dao Hong Nhung is a researcher with a background in both pharmacy and biomedical science. She began her academic journey by earning a bachelor’s degree in pharmacy in 2018, then completed her Master of Science degree in Cancer Biomedical Science at Graduate School of Cancer Science and Policy, National Cancer Center in South Korea in 2021. Her current research is innovative therapies, with a strong focus on clinical trials involving CAR-T cells, mesenchymal stem cells (MSCs), and extracellular vesicles (EVs), especially in manufacturing and laboratory operation. Given her extensive hands-on experience and meticulous attention to detail, she is certain to contribute to advance the quality control of further research at the Institute.
CAR-T cell manufacturing, evaluating safety and preliminary efficacy of CAR-T cell therapy.
Production of mesenchymal stem cells and MSC-derived Extracellular vesicles; evaluation the safety and efficacy of EVs in animal models
Van T. Hoang, Nguyen Q.T., Phan T.K.T., Pham T.H., Dinh N.T.H., Le Phuong Hoang Anh, Dao L.T.M., Bui V.D., Dao H.-N., Le D.S., et al.Tissue Engineering and Regenerative Medicine: Perspectives and Challenges. MedComm, 2025. DOI: 10.1002/mco2.70192
Dang VD, Szelinski F, Mohr E, Le TA, Ritter J, Wiedemann A, Ferreira-Gomes M, Guerra GM, Durek P, Heinrich F, Rincon-Arevalo H, Stefanski AL, Schrezenmeier E, Hoang VT, Dao HN, Ocvirk S, Cheng Q, Hiepe F, Hipfl C, Hardt S, Löhning M, Nguyen LT, Mashreghi MF, Fillatreau S, Dörner T, Lino AC. Distinct autoreactive CD19- plasma cell subsets accumulate in lupus-prone mice. Nat Commun. 2025. doi: 10.1038/s41467-025-65906-6.
• 2021: Master of Science, Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National cancer center, South Korea
• 2018: Bachelor, Pharmacy, Dai Nam University, Hanoi, Vietnam